Fig. 7
From: Recent advances of CREKA peptide-based nanoplatforms in biomedical applications
Distribution of CREKA-MSCs in the area of cardiac infarction. A Ex vivo optical imaging and semi-quantitative results of the heart injected with DiD-labeled CREKA-MSCs at different time points. B Ex vivo optical imaging and semi-quantitative analysis of other major organs in model mice treated with DiD-labeled CREKA-MSCs 3Â h. C Fluorescence micrographs of the distribution of CREKA-MSCs in the infarct area. D Quantitative analysis of transplanted cells. E Quantitative PCR of male-specific Sex-determining Region Y gene (SRY) at 1Â day, 7Â days and 2w after cell infusion [74]